FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

Sen. Johnson Wants Covid Interviews with Former FDAers, Fauci

Sen. Ron Johnson asks to interview four former CBER officials and Anthony Fauci on the safety and efficacy of Covid vaccines.

latest-news-card-1
Human Drugs

New Effectiveness Evidence Requirements Analyzed

Two Latham Watkins attorneys analyze a revised FDA draft guidance on demonstrating substantial evidence of effectiveness in drug and biologic trials a...

Human Drugs

Allure Labs FDA-483 Out

FDA releases the form FDA-483 with three observations from an inspection at the Hayward, CA-based Allure Labs drug manufacturing facility.

latest-news-card-1
Human Drugs

PolyPid NDA Accepted for Preventing Surgical Site Infection

FDA accepts for priority review a PolyPid NDA for D-PLEX100 for the prevention of surgical site infections in patients undergoing abdominal colorectal...

latest-news-card-1
FDA General

FDA Posts User Fee Rates for FY 2027

FDA posts the following user fee rates for medical product programs for fiscal year 2027.

latest-news-card-1
Human Drugs

9 Items on Bentley Laboratories FDA-483

FDA releases the form FDA-483 with nine observations from an inspection at the Edison, NJ-based Bentley Laboratories over-the-counter drug manufacturi...

latest-news-card-1
Medical Devices

Resmed Class 1 Recall of Astral Ventilators

Resmed recalls its Astral 100/150 ventilator system due to the potential for a supercapacitor electrolyte leakage on the printed circuit board assembl...

latest-news-card-1
FDA General

Dr. Oz Emerges as Potential Successor to RFK Jr. at HHS, Report Says

Bloomberg reports that Centers for Medicare & Medicaid Services head Mehmet Oz is increasingly viewed inside the Trump administration as the leading c...

latest-news-card-1
Human Drugs

Dr. Reddys Gets FDA-483 After Pre-Approval Inspection

FDA issues Dr. Reddys a three-observation Form FDA-483 following a pre-approval inspection and Good Manufacturing Practices inspection at the companys...

latest-news-card-1
Medical Devices

FDA De Novo OK for CaRi-Heart Coronary Inflammation Technology

FDA grants de novo authorization for Caristo Diagnostics CaRi-Heart coronary inflammation technology.